WeChat-based human-centered nursing support for people undergoing awake thermal ablation for papillary thyroid carcinoma
Official title: Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma
Run by China-Japan Friendship Hospital · NCT07302672 · Data updated 2026-11-12
This study tests whether WeChat-based human-centered nursing support helps people with papillary thyroid carcinoma feel less anxious and have better quality of life during and after awake thermal ablation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 16 Years to 60 Years |
| Sex | All |
| Enrollment | 108 (estimated) |
| Sponsor | China-Japan Friendship Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | December 15, 2025 |
| Main results expected | June 30, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | July 14, 2026 |
| Trial ID | NCT07302672 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people aged 16–60 with T1N0M0 papillary thyroid carcinoma (≤3 lesions, largest ≤2 cm) scheduled for awake thermal ablation who own a smartphone and can use WeChat.
✕Probably not a fit
Patients with prior thyroid surgery or ablation, serious medical or cognitive conditions, inability or unwillingness to use WeChat, or those who cannot tolerate local anesthesia are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized interventional trial compares a structured humanistic continuing-care program delivered via WeChat with usual nursing care for patients undergoing thermal ablation under local anesthesia. Participants will be assigned to receive either WeChat-based emotional support, clear communication, comfort measures, and postoperative follow-up or standard nursing care. Emotional distress and quality of life will be measured with questionnaires before the procedure, during the perioperative period, and at postoperative follow-up visits. The study is conducted at China-Japan Friendship Hospital in Beijing and requires participants to use WeChat on a smartphone.
Why it matters
Potential benefit: If successful, the intervention could lower procedure-related anxiety and improve post-procedure quality of life and recovery for patients.
How similar studies have gone: Related telehealth and human-centered nursing programs have reduced perioperative anxiety in other settings, but structured WeChat continuing care for thyroid thermal ablation is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 16-60 years; scheduled for thyroid thermal ablation * Papillary thyroid carcinoma (PTC) * Number of target lesions \<= 3 * Largest lesion diameter \<= 2 cm; clinical stage T1N0M0 by imaging * Awake and able to cooperate under local anesthesia Owns a smartphone and can use WeChat Exclusion Criteria: * Serious medical comorbidities or cognitive impairment that precludes participation * Prior thyroid surgery or thermal ablation * Unwilling or unable to join the WeChat group or complete postoperative follow-up
Where it's running
-
China-Japan Friendship Hospital
Beijing, China Recruiting
Study contacts
- Study coordinator: ming-an yu, MD
- Email: yma301@163.com
- Phone: 84205756
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transaxillary robotic thyroidectomy with modified radical neck dissection versus conventional open surgery for papillary thyroid cancer with lateral lymph node spread
This trial tests whether a transaxillary robotic thyroidectomy with modified radical neck dissection can provide similar cancer control but better cosmetic results and recovery than conventional open surgery for adults with papillary thyroid cancer that has spread to nearby neck lymph nodes.
-
Factors affecting recurrence after thermal ablation of papillary thyroid carcinoma
This study looks at patients with papillary thyroid cancer who have had thermal ablation to see what factors might affect whether their cancer comes back.
-
BIS range and propofol depth during total IV anesthesia with adjuvants for knee replacement
This study tests the right BIS range and propofol level to keep anesthesia deep enough when using propofol with midazolam, dexmedetomidine, or esketamine in knee replacement patients.
-
Bariatric Surgery Combined With GLP-1RA in Obesity Patients
This study tests whether adding a GLP-1 receptor agonist after bariatric surgery helps people with obesity lose more weight and improve metabolism.
-
Multi-patient CT-derived Digital Twin Training to Shorten the Bronchoscopy Learning Curve
This trial tests if training with digital twins from multiple CT scans helps novices learn bronchoscopy faster than standard anatomically uniform simulation training.
-
How different drugs affect BIS-EEG during anesthesia with propofol-remifentanil
This study tests how adding drugs like midazolam, dexmedetomidine, or esketamine changes BIS and raw EEG readings in adults having elective gallbladder surgery under standard anesthesia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.